
- Pharmaceutical Technology, July 2022
- Volume 46
- Issue 7
- Pages: 44–47
Application of RSD Charts for Content Uniformity Data in Continued Process Verification
This article is focused on introducing a control chart technique using relative standard deviation (RSD) statistics (i.e., RSD chart); in other words, a coefficient of variation chart for continued process verification.
Relative standard deviation (RSD) limits were used in content uniformity in the past (before 2007). From a statistical point of view, RSD is one of the only few statistics that describes the term “uniformity” best. In a simulation study conducted by the author, both acceptance value (AV) and RSD distributions have a typical relationship where it was found that AV and RSD charts, when applied for continued process verification (CPV) purpose, can be constructed concurrently on the same chart frame to demonstrate their common overlay view. While RSD calculation is much more simple, RSD charts may also be applied to confirm the validity of AV charts in CPV exercise.
Peer-reviewed research
Submitted: May 23, 2022
Accepted: June 8, 2022
About the author
Pramote Cholayudth, [email protected], is the founder and manager of PM Consult. He is an industrial pharmacist with more than 40 years of experience. He is a guest speaker on process validation to industrial pharmaceutical scientists organized by Thailand’s FDA.
Article details
Pharmaceutical Technology
Vol. 46, No. 7
July 2022
Pages: 44–47
Citation
When referring to this article, please cite it as P. Cholayudth, “Application of RSD Charts for Content Uniformity Data in Continued Process Verification,” Pharmaceutical Technology 46 (7) 44–47 (2022).
Articles in this issue
almost 4 years ago
Getting Proactive with Pharma Packagingalmost 4 years ago
Advancing Accessibility through Point-of-Use Manufacturingalmost 4 years ago
Formulating Biologics: A Learning Curvealmost 4 years ago
Innovations in Single-Cell Proteomics Drive Advances in Disease Researchalmost 4 years ago
Automating Biopharma Manufacturingalmost 4 years ago
Challenges to Formulation Development for Highly Potent APIsalmost 4 years ago
Prefilled Syringes Show Strong Growthalmost 4 years ago
Material Management and the Impact on Extractables and Leachablesalmost 4 years ago
Trends in International Arbitration: The Fallout from COVID-19almost 4 years ago
The European Union’s New Pharmaceutical Strategy for Europe



